Identification of sars-cov-2 main protease inhibitors from a library of minor cannabinoids by biochemical inhibition assay and surface plasmon resonance characterized binding affinity

HIGHLIGHTS

• who: Chang Liu and colleagues from the Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, USA have published the Article: Identification of SARS-CoV-2 Main Protease Inhibitors from a Library of Minor Cannabinoids by Biochemical Inhibition Assay and Surface Plasmon Resonance Characterized Binding Affinity, in the Journal: Molecules 2022, 27, x FOR PEER REVIEW Figure of /2022/
• what: The inhibitory effects of a collection of cannabinoids on SARS-CoV-2 3CL Mpro were screened by a biochemical assay.
• future: Future investigations including the synthesis of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.